MBD2 and colorectal carcinoma: The feasibility of the proposed approach was validated in this study by targeting an IDPR of MBD2 that undergoes a DOT upon association with its binding partner p66α for the integration of the Mi-2/NuRD chromatin remodeling complex (CRC).